Calcipotriol - Polichem

Drug Profile

Calcipotriol - Polichem

Alternative Names: P 3073

Latest Information Update: 15 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Polichem
  • Class Antipsoriatics; Cyclohexanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Psoriasis

Most Recent Events

  • 10 Jan 2018 Polichem withdraws a phase III trial in Psoriasis in USA (NCT03079973)
  • 28 Mar 2017 Polichem plans a phase III trial for Psoriasis in USA (NCT03079973)
  • 08 Feb 2017 Polichem completes a phase III trial in Psoriasis in Bulgaria, Czech Republic, Germany, Greece, Latvia, Poland and Russia (Topical) (EudraCT2015-002365-34)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top